AXDX Past Earnings image   This AXDX past earnings page last updated 7/11/2024
AXDX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/8/2024-0.880
Q4 20233/28/2024-0.890
Q3 202311/9/2023-1.180
Q2 20238/10/2023-1.310
Q1 20235/11/2023-1.700
Q4 20223/29/2023-1.500
Q3 202211/14/2022-1.800
Q2 20228/15/2022-2.300
Q1 20225/16/2022-2.500
Q4 20213/8/2022-2.300
Q3 202111/9/2021-3.100
Q2 20218/5/2021-3.600
Q1 20215/6/2021-4.100
Q4 20202/23/2021-3.300
Q3 202011/5/2020-3.300
Q2 20208/6/2020-3.500
Q1 20205/7/2020-3.900
Q4 20192/27/2020-3.900
Q3 201911/7/2019-3.700
Q2 20198/8/2019-3.800
Q1 20195/9/2019-4.000
Q4 20182/19/2019-4.100
Q3 201811/6/2018-4.100
Q2 20188/6/2018-3.700
Q1 20185/9/2018-3.700
Q4 20172/15/2018-2.700
Q3 201711/2/2017-3.100
Q2 20178/3/2017-3.100
Q1 20175/3/2017-2.700
Q4 20162/27/2017-3.100
Q3 201611/9/2016-3.400
Q2 20168/8/2016-3.500
AXDX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.00B
Q4 20233/28/20240.00B
Q3 202311/9/20230.00B
Q2 20238/10/20230.00B
Q1 20235/11/20230.00B
Q4 20223/29/20230.00B
Q3 202211/14/20220.00B
Q2 20228/15/20220.00B
Q1 20225/16/20220.00B
Q4 20213/8/20220.00B
Q3 202111/9/20210.00B
Q2 20218/5/20210.00B
Q1 20215/6/20210.00B
Q4 20202/23/20210.00B
Q3 202011/5/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.00B
Q4 20192/27/20200.00B
Q3 201911/7/20190.00B
Q2 20198/8/20190.00B
Q1 20195/9/20190.00B
Q4 20182/19/20191.82M
Q3 201811/6/20181.35M
Q2 20188/6/20181.69M
Q1 20185/9/2018801000
Q4 20172/15/20182.06M
Q3 201711/2/2017828000
Q2 20178/3/2017699000
Q1 20175/3/2017530000
Q4 20162/27/201739000
Q3 201611/9/201624000
Q2 20168/8/201620000
Quotes delayed 20 minutes

Email EnvelopeFree AXDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Accelerate Diagnostics (AXDX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AXGN Past Earnings
AXLA Past Earnings
AXNX Past Earnings
AXSM Past Earnings
AYTU Past Earnings
AZRX Past Earnings
AZYO Past Earnings
BACK Past Earnings
BAX Past Earnings
BBI Past Earnings

AXDX Past Earnings Q&A

What was the best and worst AXDX past earnings results?
For Accelerate Diagnostics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest AXDX past earnings result in our data set was -0.880/share posted in Q1 2024, while the lowest was in Q1 2021 when AXDX posted -4.100/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when AXDX reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q2 2016 at 20000 of revenue.

  Suggested answer: There are 32 AXDX past earnings results in our data set.

On this page we presented the AXDX past earnings date information for Accelerate Diagnostics. Reviewing that AXDX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2024, when AXDX posted gaap of -0.880/share. Meanwhile the lowest AXDX past earnings result was in Q1 2021, when AXDX posted gaap of -4.100/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when AXDX reported 0.00B in revenue, while the smallest revenue quarter was Q2 2016 when AXDX reported 20000 in revenue.

Any self directed investor doing their due diligence on AXDX or any other given stock can benefit from researching all of the Accelerate Diagnostics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Accelerate Diagnostics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AXDX. Thanks for visiting, and the next time you need to research AXDX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: NLY Historical Stock Prices, OPRT Insider Buying, NAVR Split History.

 

AXDX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.